A histopathological study of nephrotoxicity, hepatoxicity or testicular toxicity: Which one is the first observation as side effect of Cisplatin-induced toxicity in animal model?
BACKGROUND
Cisplatin (CP) is widely used in clinic to treat the solid tumors. However, CP is associated with some major side effects including nephrotoxicity, hepatoxicity, and testicular toxicity.


OBJECTIVE
To found, which of the toxicities is the first side effect of CP.


METHODS
we conducted a pilot research on 12 adult male Wistar rats.


RESULTS
One week after CP administration, the induced toxicity was observed clearly in kidney tissue. The only abnormality that observed in testis tissue was very small degree of hyaline casts. However, no damage and other abnormality were detected in the liver tissue.


CONCLUSIONS
According to these findings, in clinic, first special attention must be made on kidneys during chemotherapy with CP. However, the duration of experiment is suggested to be extended to obtain hepatoxicity or testicular toxicity model in experimental animal in laboratories. Moreover, different dose of CP should be used to study the first side effect in animal model.
Water & Electrolytes Research Center, Isfahan University of Medical Sciences Isfahan, Iran. ; Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran. ; Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Mehdi
M
Nematbakhsh
Water & Electrolytes Research Center, Isfahan University of Medical Sciences Isfahan, Iran. ; Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Farzaneh
F
Ashrafi
Water & Electrolytes Research Center, Isfahan University of Medical Sciences Isfahan, Iran.
Zahra
Z
Pezeshki
Clinical Pathologist, Isfahan, Iran.
Zahra
Z
Fatahi
Water & Electrolytes Research Center, Isfahan University of Medical Sciences Isfahan, Iran.
Fariborz
F
Kianpoor
Department of Clinical Pathology, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohammad-Hossein
MH
Sanei
Department of Clinical Pathology, Isfahan University of Medical Sciences, Isfahan, Iran.
Ardeshir
A
Talebi
Cisplatin; Hepatoxicity; Nephrotoxicity; Toxicity